00241 PE Ratio & Valuation,Is 00241 Overvalued — Intellectia
00241 Relative Valuation
00241's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, 00241 is overvalued; if below, it's undervalued.
Historical Valuation
ALI HEALTH(00241) is now in theFairzone, suggesting that its currentforward PSratio of0.00is consideredFairlycompared with the five-year average of94.24.The fair price ofALI HEALTH(00241)is betweenNaNtoNaNaccording to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：5.30
Fair
29.68
PE
1Y
3Y
5Y
Trailing
Forward
24.93
EV/EBITDA
ALI HEALTH. (00241) has a current EV/EBITDA of 24.93. The 5-year average EV/EBITDA is -158.93. The thresholds are as follows: Strongly Undervalued below -2330.86, Undervalued between -2330.86 and -1244.90, Fairly Valued between 927.03 and -1244.90, Overvalued between 927.03 and 2012.99, and Strongly Overvalued above 2012.99. The current Forward EV/EBITDA of 24.93 falls within the Historic Trend Line -Fairly Valued range.
25.36
EV/EBIT
ALI HEALTH. (00241) has a current EV/EBIT of 25.36. The 5-year average EV/EBIT is -600.34. The thresholds are as follows: Strongly Undervalued below -6515.43, Undervalued between -6515.43 and -3557.88, Fairly Valued between 2357.21 and -3557.88, Overvalued between 2357.21 and 5314.75, and Strongly Overvalued above 5314.75. The current Forward EV/EBIT of 25.36 falls within the Historic Trend Line -Fairly Valued range.
2.02
PS
ALI HEALTH. (00241) has a current PS of 2.02. The 5-year average PS is 3.35. The thresholds are as follows: Strongly Undervalued below -2.77, Undervalued between -2.77 and 0.29, Fairly Valued between 6.41 and 0.29, Overvalued between 6.41 and 9.47, and Strongly Overvalued above 9.47. The current Forward PS of 2.02 falls within the Historic Trend Line -Fairly Valued range.
24.58
P/OCF
ALI HEALTH. (00241) has a current P/OCF of 24.58. The 5-year average P/OCF is -77.50. The thresholds are as follows: Strongly Undervalued below -1498.69, Undervalued between -1498.69 and -788.09, Fairly Valued between 633.10 and -788.09, Overvalued between 633.10 and 1343.69, and Strongly Overvalued above 1343.69. The current Forward P/OCF of 24.58 falls within the Historic Trend Line -Fairly Valued range.
28.45
P/FCF
ALI HEALTH. (00241) has a current P/FCF of 28.45. The 5-year average P/FCF is 1279.73. The thresholds are as follows: Strongly Undervalued below -9181.21, Undervalued between -9181.21 and -3950.74, Fairly Valued between 6510.20 and -3950.74, Overvalued between 6510.20 and 11740.66, and Strongly Overvalued above 11740.66. The current Forward P/FCF of 28.45 falls within the Historic Trend Line -Fairly Valued range.
ALI HEALTH (00241) has a current Price-to-Book (P/B) ratio of 4.37. Compared to its 3-year average P/B ratio of 4.00 , the current P/B ratio is approximately 9.30% higher. Relative to its 5-year average P/B ratio of 5.94, the current P/B ratio is about -26.49% higher. ALI HEALTH (00241) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 1.39%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 1.12% , the current FCF yield is about -100.00% lower.
4.37
P/B
Median3y
4.00
Median5y
5.94
1.83
FCF Yield
Median3y
1.39
Median5y
1.12
Performance Decomposition
1Y
3Y
5Y
Market capitalization of 00241 increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of 00241 in the past 1 year is driven by Unknown.
Is ALI HEALTH (00241) currently overvalued or undervalued?
ALI HEALTH(00241)is now in theFairzone, suggesting that its currentforward PSratio of 0.00is consideredFairlycompared with the five-year average of94.24.The fair price of ALI HEALTH(00241)is betweenNaNtoNaNaccording to relative valuation methord.
What is ALI HEALTH (00241) fair value?
00241's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of ALI HEALTH (00241) is between NaNtoNaN according to relative valuation methord.
How does 00241's valuation metrics compare to the industry average?
The average P/S ratio for 00241's competitors is , providing a benchmark for relative valuation. ALI HEALTH Corp (00241) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for ALI HEALTH (00241) as of Dec 18 2025?
As of Dec 18 2025, ALI HEALTH (00241) has a P/B ratio of 4.37. This indicates that the market values 00241 at 4.37 times its book value.
What is the current FCF Yield for ALI HEALTH (00241) as of Dec 18 2025?
As of Dec 18 2025, ALI HEALTH (00241) has a FCF Yield of 0.00%. This means that for every dollar of ALI HEALTH’s market capitalization, the company generates 0.00 cents in free cash flow.
What is the current Forward P/E ratio for ALI HEALTH (00241) as of Dec 18 2025?
As of Dec 18 2025, ALI HEALTH (00241) has a Forward P/E ratio of 29.68. This means the market is willing to pay $29.68 for every dollar of ALI HEALTH’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for ALI HEALTH (00241) as of Dec 18 2025?
As of Dec 18 2025, ALI HEALTH (00241) has a Forward P/S ratio of 0.00. This means the market is valuing 00241 at $0.00 for every dollar of expected revenue over the next 12 months.
